Showing results (301-310 of 460) with videos related to
Sort By:
Pageof 46
Aktuelle Gerontologie|September 1, 1980
[Age dependence of vascular prostacyclin formation in man (author's transl)]C Leithner, H Sinzinger, G Schernthaner, et al.Wiener Medizinische Wochenschrift (1946)|January 1, 1990
[Risk factors of atherosclerosis and awareness of risk in employees of a Viennese insurance company]K Weiss, S Egger, P Hirmann, et al.Agents and Actions. Supplements|January 1, 1992
Prostaglandin (PG) E1 and 13,14-dihydro (DH) PGE1 are diminishing radiation-induced arterial damageI Neumann, W Rogatti, I Virgolini, et al.Thrombosis Research|May 15, 1991
Interaction between prostaglandin E1 and nitric oxide (NO)R Katzenschlager, K Weiss, W Rogatti, et al.British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.Acta Medica Austriaca|January 1, 1985
[Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]W Linkesch, H Gisslinger, H Ludwig, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1989
Prostacyclin I2 (PGI2) increases left ventricular ejection fraction (LVEF)C Auinger, I Virgolini, M Weissel, et al.British Journal of Clinical Pharmacology|February 1, 1990
99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitroI Virgolini, P Angelberger, C Müller, et al.Experientia|November 15, 1978
Prostacyclin-like activity of endothelium and subendothelium - important for atherosclerosis?K Silberbauer, H Sinzinger, M Winter, et al.Platelets|November 4, 2010
Influence of a single dose of calcium channel blockers on platelet functionK Weiss, P Fitscha, I Virgolini, et al.Pageof 46